Research Grant Opportunities

NEW RESEARCH OPPORTUNITY

To American-Lung-Associationencourage research on advancing the understanding of Alpha-1 Antitrypsin Deficiency, the American Lung Association (ALA) has teamed up with the Alpha-1 Foundation to offer the Alpha-1 Research Grant. New A1F Logo_No BackgroundThe objective of the Research Grant is to support clinical, laboratory, epidemiological or any other kind of research projects aimed at developing novel medical treatments, advancing current treatment options or finding a cure for Alpha-1.

The Alpha-1 Research Grant is for $40,000 per year. The period of performance for this award is July 1, 2015 through June 30, 2017.

APPLICATION DEADLINE

A letter of intent is not required for the Alpha-1 Research Grant. All applications must be submitted electronically through proposalCENTRAL by March 4, 2015. Eligibility requirements and application instructions are available through proposalCENTRAL.

FOR QUESTIONS ABOUT THIS GRANT OPPORTUNITY, PLEASE CONTACT:

David Fernandez, Manager of Research Administration, Alpha-1 Foundation
dfernandez@alpha1.org
or
Elizabeth Lancet, Assistant Vice President, Research, American Lung Association
Elizabeth.Lancet@Lung.org

 

 

The Alpha-1 Foundation offers research opportunities for both in-cycle and out-of-cycle timelines. Please read the following for more information on the two grants.

IN-CYCLE GRANT OPPORTUNITY INFORMATION

Letter of Intent

Deadline for our receipt of your in-cycle LOI, Biographical Sketch and Keywords List: September 19, 2014, 5 p.m. EDT.

The first step in the process of a grant application to the Alpha-1 Foundation is to submit an LOI, Biographical Sketch and Keywords list. All three documents must be submitted to the Foundation by September 19, 2014, 5PM EDT in order to be invited to submit a full grant application. The submission of an LOI is required for each grant category. An applicant must submit an LOI in order to submit a grant application. A grant application that is submitted without an LOI will result in an automatic denial of funding and the application will be returned to the investigator. Click the following links for information and instructions regarding the submission of an LOI and grant application:

Research Opportunities Timeline
LOI and Grant Application Instructions
Letter of Intent Form
Biographical Sketch for LOI
LOI and Grant Application Keywords List

For information about the Foundation’s in-cycle grant opportunities, please contact David Fernandez, Manager of Research Administration, at dfernandez@alpha1.org or at (877) 228-7321 ext. 242.

GRANT APPLICATION

Deadline for our receipt of your in-cycle grant application: February 13, 2015, 5 p.m. EDT.

If your LOI is approved, the Alpha-1 Foundation will invite you to submit a full grant application. Please note that a LOI must be submitted, reviewed and approved prior to submitting a grant application. Click the following links for information and instructions regarding the submission of a grant application:

Research Opportunities Timeline 
LOI and Grant Application Instructions
Grant Application Forms
General Terms and Conditions Governing Grant Awards
Frequently Asked Questions

For information about the Alpha-1 Foundation’s in-cycle grant application process or requirements, please contact David Fernandez, Manager of Research Administration, at dfernandez@alpha1.org or at (877) 228-7321 ext. 242.

IN CYCLE RESEARCH GRANT CATEGORIES:

Bridge Grant

Funding Level: Maximum of $25,000 may be requested.

Period: Up to 1 year of support is available.

The objective of this grant is to provide support for excellent Alpha-1 Antitrypsin (AAT) Deficiency-related research projects that have been submitted to and approved by the National Institutes of Health (NIH), but cannot be supported by the available NIH funds. Thus, this award complements the granting mechanism of the NIH for projects of potential interest to individuals served by the Alpha-1 Foundation. Funds provided by the Alpha-1 Foundation through this program are intended to lead to the development of sufficient preliminary data to make AAT-related applications highly competitive in the NIH review process. Information derived from Alpha-1 Foundation supported research studies is intended to lead to solicitation of additional, subsequent funds from other agencies such as the NIH.

Pilot and Feasibility Grant

Funding Level: Maximum of $40,000 may be requested.

Period: Up to 1 year of support is available.

The objective of this grant is to provide funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to AAT Deficiency. Proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in AAT research or development of novel methods, and providing sufficient preliminary data to justify the Foundation’s support. Results from Pilot and Feasibility Grants should lead to the submission of applications for funding from other agencies (i.e. NIH). At the conclusion of the funding term, applicants are expected to apply for further funding by other mechanisms or from outside agencies. The award is not intended to support continuation of programs begun under other granting mechanisms.

Postdoctoral Research Fellowship Grant

Funding Level: Maximum of $50,000 per year may be requested.

Period: Up to 2 years of support is available.

The objective of this grant is to provide support for postdoctoral research fellows who are starting their research careers and are working in the laboratories of established researchers or conducting research with the mentorship of established researchers. In addition, this grant category is intended to provide support for postdoctoral research fellows who intend to pursue a career in AAT research. Applications will be accepted from candidates holding an M.D., Ph.D. or equivalent degrees who are interested in conducting basic science, clinical research, or ethic, legal, social issues studies related to AAT Deficiency. Applicants must indicate a commitment to AAT-related research by focusing 50% of their time to AAT Deficiency research or clinical practice.

Research Grant

Funding Level: Maximum of $100,000 per year may be requested.

Period: Up to 2 years of support is available.

The objective of this grant is to provide funds to encourage the development of new information that contributes to the understanding of the basic biology of AAT expression, and the pathogenesis/management of AAT Deficiency. In addition, consideration will be given to those projects that provide insight into the development of information that may contribute to new therapies for AAT Deficiency. All proposals must be hypothesis generating or hypothesis testing and provide sufficient preliminary data to justify the Alpha-1 Foundation’s support.

Scientific Meeting Sponsorship Grant

Funding Level: Grants are generally funded at the $5,000 level. The funds are restricted for use during a specified period of time.

Period: Varies according to request.

The objective of this grant is to provide support for scientific meetings, workshops or conferences relevant to AAT Deficiency and the Alpha-1 Foundation’s mission statement.

Travel Grant

Funding Level: Grants are generally funded at a level of $1,000. The funds are restricted for use during a specified period of time.

Period: Varies according to request.

There are 2 types of Travel Grants:

  • The Alpha-1 Foundation provides funds to support travel to attend a scientific conference or meeting to present AAT-related abstracts or posters at national and international meetings. Candidates must have an M.D., Ph.D. or equivalent degree, and at least one year of recent research experience related to AAT Deficiency. The award is intended primarily for travel support for an award recipient. If the grant is to be used for specialized training, a letter of support for the individual must be presented, and clearly indicate the visitor’s role, time commitment and objectives for the proposed training as well as institutional commitment.
  • The Alpha-1 Foundation provides funds to support cross training at an established Alpha-1 laboratory by an established Alpha-1 investigator. Training may include training on diagnostic and therapeutic procedures, research related techniques, training on specialized equipment or software applicable to AAT-related research.

 


OUT-OF-CYCLE GRANT OPPORTUNITIES

The purpose of this program is to support large, typically clinical grants that do not fit into the in-cycle grant program. Out-of-cycle grants can be Foundation-initiated RFA or Investigator-initiated applications. The investigator should contact the Foundation before considering applying for an out-of-cycle application.

For more information, about the Alpha-1 Foundation’s out-of-cycle grant opportunities, please contact David Fernandez, Manager of Research Administration, at dfernandez@alpha1.org or at (877) 228-7321 ext. 242.